← Back
Data updated: Jul 17, 2026
CIS BIO INTL SA
Pharma Pharmaceuticals
CIS BIO INTL SA is a pharmaceutical company with 2 FDA-approved products.
1998
Since
2
Drugs
-
Trials
0
New Drugs (2yr)
CIS BIO INTL SA's Key Drugs
CIS BIO INTL SA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
CIS BIO INTL SA's Recent FDA Approvals
New NDA/BLA approvals for CIS BIO INTL SA over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
CIS BIO INTL SA's Therapeutic Areas
Disease areas where CIS BIO INTL SA has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CIS BIO INTL SA Pipeline Snapshot
Active clinical trials for CIS BIO INTL SA across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1998-09-14
- Latest
- 2004-10-01
- Applications
- 2